Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhDGlobeNewsWire • 09/06/23
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 08/14/23
CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)Accesswire • 07/21/23
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)Accesswire • 07/21/23
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney ConferenceGlobeNewsWire • 07/20/23
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of NephrologyGlobeNewsWire • 07/18/23
Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate ProgramGlobeNewsWire • 06/29/23
Unicycive to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ETGlobeNewsWire • 06/16/23
Unicycive Therapeutics, Inc. and Alarum Technologies Ltd. Interviews to Air on Bloomberg TV on the RedChip Money Report®Accesswire • 06/09/23
Unicycive Announces First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/16/23
Unicycive Announces Acceptance of Multiple Datasets to Be Presented at the European Renal Association CongressGlobeNewsWire • 04/24/23
Unicycive Announces Full Year 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/31/23
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug RenazorbGlobeNewsWire • 03/06/23
Unicycive to Highlight Potential of UNI-494 to Restore Mitochondrial Function and Reduce Oxidative Stress at Two Upcoming Medical and Scientific MeetingsGlobeNewsWire • 02/27/23
Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of KoreaGlobeNewsWire • 02/02/23
Unicycive Announces Acceptance of Three Abstracts for Presentation at the National Kidney Foundation's Spring Clinical MeetingsGlobeNewsWire • 01/23/23
Unicycive Announces Acceptance of Four Abstracts for Presentation at the World Congress of Nephrology 2023GlobeNewsWire • 01/05/23
Unicycive Announces Termination of “At-The-Market” Offering of Shares of Common StockGlobeNewsWire • 12/29/22
Unicycive Achieves Primary Endpoint in Pivotal Bioequivalence Study of RenazorbGlobeNewsWire • 12/28/22